RNA, U2 small nuclear 66, pseudogene (RNU2-66P)

RNA, U2 small nuclear 66, pseudogene (RNU2-66P) is classified as a pseudogene in the human genome. It is related to U2 small nuclear RNA (snRNA), which is a critical component of the spliceosome machinery involved in pre-mRNA splicing, but RNU2-66P itself does not produce a functional RNA molecule or protein product[1][2][6]. As a pseudogene, it is generally considered genetically inactive, and there is no evidence that it serves as a therapeutic target, is associated with disease, or interacts with drugs. Key supporting details: - RNU2-66P is listed as a pseudogene both by GeneCards[1] and NCBI[6], with no documented protein product, interaction, or known function. - U2 snRNA (active forms, not the pseudogene) is essential in the spliceosome, but pseudogene variants such as RNU2-66P simply represent nonfunctional remnants, typically with no pathological or pharmacological relevance[1][2][6]. - There are no alternative names, known disease roles, drug interactions, biomarkers, or therapeutic safety concerns associated with RNU2-66P in the biomedical literature or main genetic databases[1][2][6].